108 results on '"Sambade, Maria"'
Search Results
2. 848 Predictions of endogenous neoantigens from varied genomic sources in a syngeneic murine cancer model
3. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases
4. Supplemental Methods from Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer
5. Supplemental Table from Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer
6. Supplemental Figure Legends from Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer
7. Data from Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer
8. Supplemental Figures S1-S9 from Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer
9. Repair of Thalassemic Human β -globin mRNA in Mammalian Cells by Antisense Oligonucleotides
10. BSCI-06 COMPREHENSIVE ANALYSIS OF THE IMMUNOGENOMICS OF TRIPLE NEGATIVE BREAST CANCER BRAIN METASTASES FROM LCCC1419
11. Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419
12. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032
13. SARS-CoV-2 peptide vaccine elicits T-cell responses in mice but does not protect against infection or disease
14. Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
15. Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts
16. Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf > MEK > ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK
17. MERTK receptor tyrosine kinase is a therapeutic target in melanoma
18. Additional file 1 of Landscape and selection of vaccine epitopes in SARS-CoV-2
19. Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
20. Mechanisms of Chromosomal Instability in Melanoma
21. A genomic screen for yeast vacuolar membrane ATPase mutants
22. MERTK receptor tyrosine kinase is a therapeutic target in melanoma
23. A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines
24. 258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
25. 478 Translation of a therapeutic neoantigen vaccine workflow to SARS-CoV-2 vaccine development
26. Landscape and Selection of Vaccine Epitopes in SARS-CoV-2
27. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides
28. THER-06. GENOMIC AND IMMUNE CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER BRAIN METASTASES
29. Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine models
30. Abstract 4055: Genomic and immune characterization of triple-negative breast cancer brain metastases
31. Abstract 2813: Efficacy and pharmacokinetics of niraparib in BRCA-mutant and wild-type intracranial triple negative breast cancer murine models
32. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
33. Abstract A03: Several rational combination kinase inhibitor treatments identified by synthetic lethality screens are efficacious in intracranial triple negative breast cancer models
34. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer
35. Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT® nanoparticle formulation against non-small-cell lung cancer brain metastases
36. Abstract 3867: Combined PI3K and AURKA inhibition are efficacious in triple-negative breast cancer models
37. Abstract 2579: Combination therapy with MEK inhibition is efficacious in intracranial triple negative breast cancer models
38. Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer
39. Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK
40. Abstract 3037: Mer receptor tyrosine kinase is a novel therapeutic target in melanoma.
41. Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT® nanoparticle formulation against non-small-cell lung cancer brain metastases.
42. Abstract B73: Lapatinib‐mediated radiosensitization of EGFR+/basal breast cancer correlates withERK inhibitionin vivoand requires MEK/ERK inhibitionin vitro
43. Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK
44. The Yeast Vacuolar Proton-translocating ATPase Contains a Subunit Homologous to the Manduca sexta and Bovine e Subunits That Is Essential for Function
45. Sensitivity of splice sites to antisense oligonucleotides in vivo
46. Ultrastructural Appearance of Amyloid.
47. Hürthle-Cell Lesions of the Thyroid: A Combined Study Using Transmission Electron Microscopy, Scanning Electron Microscopy, and Immunocytochemistry.
48. High relative frequency of thyroid papillary carcinoma in northern Portugal.
49. Latent thyroid carcinoma at autopsy: a study from Oporto, Portugal.
50. Latent thyroid carcinoma at autopsy:A study from Oporto, Portugal
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.